Michael I. Jesson
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Peptidase Inhibition and Analysis
Papers in
- Oncology 13
- Cytokine Signaling Pathways and Interactions 7
- Peptidase Inhibition and Analysis 4
-
- Immune Cell Function and Interaction 4
- Co-authors
- Martin E. DowtyDebra M. MeyerNandini KishoreBarry JonesSarbani GhoshSharlene AdamsGlenn T. MillerBarbara Wallner
- Journals
- Cancer Research (3 papers)The Journal of Immunology (2 papers)Inflammation Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Immunology (1 paper)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Michael I. Jesson
21 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Rheumatology 502
- Oncology 666
- Hematology 255
- Immunology 467
- Genetics 195
Countries citing papers authored by Michael I. Jesson
This map shows the geographic impact of Michael I. Jesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael I. Jesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael I. Jesson more than expected).
Fields of papers citing papers by Michael I. Jesson
This network shows the impact of papers produced by Michael I. Jesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael I. Jesson. The network helps show where Michael I. Jesson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael I. Jesson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 112 | |
| 2 | 2019 | 81 | |
| 3 | 2018 | 26 | |
| 4 | 2014 | 42 | |
| 5 | 2013 | 88 | |
| 6 | Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550) Hit paper breakdown → | 2011 | 514 |
| 7 | 2010 | 21 | |
| 8 | 2010 | 384 | |
| 9 | Immune mechanism of action of talabostat: a dipeptidyl peptidase targeted antitumor agent | 2007 | 6 |
| 10 | Inhibitors of the stromal protease fibroblast activation protein attenuate tumor growth in vivo | 2006 | 3 |
| 11 | 2004 | 166 | |
| 12 | 2003 | 13 | |
| 13 | 2003 | 49 | |
| 14 | 1998 | 8 | |
| 15 | 1997 | 6 | |
| 16 | 1996 | 8 | |
| 17 | 1993 | 11 | |
| 18 | 1990 | 1 | |
| 19 | Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin. | 1989 | 15 |
| 20 | Effects of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues on DNA in HT-29 human colon carcinoma cells. | 1987 | 15 |
About Michael I. Jesson
Michael I. Jesson is a scholar working on Oncology, Immunology, Toxicology, Genetics and Cancer Research, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (7 papers), Immune Cell Function and Interaction (4 papers), Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Synthesis and Biological Evaluation (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Rheumatology (502 citations), Oncology (666 citations), Hematology (255 citations), Immunology (467 citations) and Genetics (195 citations). Michael I. Jesson has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Martin E. Dowty, Debra M. Meyer, Nandini Kishore, Barry Jones, Sarbani Ghosh, Sharlene Adams, Glenn T. Miller, Barbara Wallner, Takeshi Watanabe and Dale L. Morris. Their work appears in journals such as Cancer Research, The Journal of Immunology, Inflammation Research, Journal of Pharmacology and Experimental Therapeutics and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.